E. Huber

652 total citations
34 papers, 382 citations indexed

About

E. Huber is a scholar working on Ophthalmology, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, E. Huber has authored 34 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Ophthalmology, 7 papers in Surgery and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in E. Huber's work include Nasolacrimal Duct Obstruction Treatments (8 papers), Neonatal and fetal brain pathology (7 papers) and Child and Adolescent Psychosocial and Emotional Development (3 papers). E. Huber is often cited by papers focused on Nasolacrimal Duct Obstruction Treatments (8 papers), Neonatal and fetal brain pathology (7 papers) and Child and Adolescent Psychosocial and Emotional Development (3 papers). E. Huber collaborates with scholars based in Austria, Germany and China. E. Huber's co-authors include F. J. Steinkogler, E. Arocker‐Mettinger, A. Kuchar, V. Huber‐Spitzy, Ursula Stanzl, Markus Theurl, Wilfried Schgoer, Astrid Bock, Christina Steger and Dominik Wiedemann and has published in prestigious journals such as Circulation, PLoS ONE and Neuroscience.

In The Last Decade

E. Huber

33 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. Huber Austria	9	100	85	80	72	55	34	382
Ioannis P. Glavas United States	13	140 1.4×	64 0.8×	76 0.9×	147 2.0×	71 1.3×	21	363
Suk‐Woo Yang South Korea	13	42 0.4×	227 2.7×	65 0.8×	69 1.0×	64 1.2×	31	530
Donal Brosnahan Ireland	13	30 0.3×	73 0.9×	105 1.3×	20 0.3×	43 0.8×	25	421
Fabrício Souza Neves Brazil	16	37 0.4×	123 1.4×	113 1.4×	16 0.2×	12 0.2×	46	539
David Chan United States	10	163 1.6×	25 0.3×	41 0.5×	67 0.9×	71 1.3×	25	490
E H Jellinek United Kingdom	12	74 0.7×	25 0.3×	70 0.9×	26 0.4×	125 2.3×	26	506
Lorraine Cassidy Ireland	16	38 0.4×	314 3.7×	141 1.8×	15 0.2×	139 2.5×	39	608
Sevda İsmailoğulları Türkiye	11	44 0.4×	35 0.4×	27 0.3×	13 0.2×	104 1.9×	36	432
Mary Romano Italy	16	82 0.8×	469 5.5×	214 2.7×	12 0.2×	24 0.4×	53	768
Sara T. Wester United States	14	61 0.6×	207 2.4×	50 0.6×	61 0.8×	137 2.5×	50	498

Countries citing papers authored by E. Huber

Since Specialization

Citations

This map shows the geographic impact of E. Huber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Huber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Huber more than expected).

Fields of papers citing papers by E. Huber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Huber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Huber. The network helps show where E. Huber may publish in the future.

Co-authorship network of co-authors of E. Huber

This figure shows the co-authorship network connecting the top 25 collaborators of E. Huber. A scholar is included among the top collaborators of E. Huber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Huber. E. Huber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cailes, B., E. Huber, Omar Farouque, et al.. (2025). Blunted cardiac reserve as a marker of cirrhotic cardiomyopathy—Cardiac outcomes following liver transplantation and comparison to the existing guidelines. American Journal of Transplantation. 25(9). 1976–1986. 1 indexed citations

Mayer, E, et al.. (2024). Effects of DHEA and DHEAS in Neonatal Hypoxic–Ischemic Brain Injury. Antioxidants. 13(12). 1542–1542.

Huber, E., et al.. (2024). Factors Influencing Breast Milk Antibody Titers during the Coronavirus Disease 2019 Pandemic: An Observational Study. Nutrients. 16(14). 2320–2320. 1 indexed citations

Greaves, Lorraine, et al.. (2024). Vaping guidance and women's decision-making during pregnancy & postpartum. Public Health in Practice. 9. 100570–100570. 1 indexed citations

Urbanek, Martina, et al.. (2023). Investigation of secretoneurin as a potential biomarker of brain injury in very preterm infants: A pilot study. PLoS ONE. 18(4). e0284096–e0284096. 2 indexed citations

Huber, E., et al.. (2022). MicroRNA Expression Profiles as Diagnostic and Prognostic Biomarkers of Perinatal Asphyxia and Hypoxic-Ischaemic Encephalopathy. Neonatology. 119(2). 204–213. 8 indexed citations

Huber, E., et al.. (2020). The effect of levomepromazine on the healthy and injured developing mouse brain – An in vitro and in vivo study. IBRO Reports. 9. 247–257. 1 indexed citations

Huber, E., et al.. (2019). Excitotoxicity Alters Endogenous Secretoneurin Plasma Levels, but Supplementation with Secretoneurin Does Not Protect Against Excitotoxic Neonatal Brain Injury. Neuroscience. 410. 239–253. 3 indexed citations

Huber, E., et al.. (2017). Nonverbal Processes in Psychotherapeutic Interaction. 4(1). 1–8. 4 indexed citations

10.

Mueller, Markus M., M. K. Hourfar, E. Huber, et al.. (2012). Oxygen measurements in platelet fluids – a new non‐invasive method to detect bacterial contaminations in platelets. Transfusion Medicine. 22(3). 211–216. 5 indexed citations

11.

Demetz, Egon, Ivan Tancevski, Ursula Stanzl, et al.. (2012). Inhibition of hepatic scavenger receptor-class B type I by RNA interference decreases atherosclerosis in rabbits. Atherosclerosis. 222(2). 360–366. 12 indexed citations

12.

Tancevski, Ivan, Andreas Wehinger, Egon Demetz, et al.. (2008). The thyromimetic T-0681 protects from atherosclerosis. Journal of Lipid Research. 50(5). 938–944. 29 indexed citations

13.

Huber, E., G. Kiss, Thomas Berger, Peter Rehder, & H. Madersbacher. (2007). Der Stellenwert der intravesikalen Elektrostimulation in der Therapie der akuten prolongierten Blasenüberdehnung. Der Urologe. 46(6). 662–666. 5 indexed citations

14.

Kuchar, A., E. Huber, F. J. Steinkogler, & F. Karnel. (1995). [Monoca silicone intubation of the lacrimal ducts after retrograde dilatation].. PubMed. 92(1). 43–5. 2 indexed citations

15.

Soliman, Thomas, N. Neuhold, Bruno Niederle, et al.. (1994). CD15 (LeuM1) immunoreactivity: Prognostic factor for sporadic and hereditary medullary thyroid cancer?. World Journal of Surgery. 18(4). 583–587. 11 indexed citations

16.

Steinkogler, F. J., E. Huber, V. Huber‐Spitzy, & A. Kuchar. (1994). The treatment of congenital nasolacrimal duct obstruction: Primary sufficient therapy avoids chronic inflammation or dacryocystorhinostomy. Orbit. 13(1). 3–10. 6 indexed citations

17.

Steinkogler, F. J., A. Kuchar, E. Huber, & E. Arocker‐Mettinger. (1993). Gore-Tex Soft-Tissue Patch Frontalis Suspension Technique in Congenital Ptosis and in Blepharophimosis-Ptosis Syndrome. Plastic & Reconstructive Surgery. 92(6). 1057–1060. 75 indexed citations

18.

Huber‐Spitzy, V., et al.. (1992). Acquired dacryocystitis: Microbiology and conservative therapy. Acta Ophthalmologica. 70(6). 745–749. 50 indexed citations

19.

Huber, E., F. J. Steinkogler, & F. Karnel. (1991). Videodocumentation in digital dacryocystography. International Ophthalmology. 15(6). 407–409. 2 indexed citations

20.

Huber‐Spitzy, V., et al.. (1991). Norfloxacin in the treatment of congenital dacryocystitis°. Orbit. 10(1). 37–40. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact